qPCR Reagents Market Size is valued at USD 2,193.9 million in 2021 and is poised to grow at a significant CAGR of 7.9% over 2022–2028. A real-time polymerase chain reaction (real-time PCR) or quantitative polymerase chain reaction (qPCR), is a research laboratory technique of molecular biology created on the polymerase chain reaction (PCR). Globally occurrence of infectious diseases and genetic disorders increases the demand for qPCR tests. The market has witnessed high demand for qPCR core kits over the past years, due of the low prices of core kits. As a result, the market for qPCR Reagents expands due to the growing acceptance of qPCR Reagents. Companies are speeding up to grow their market shares and make technology investments to take benefit from the market’s growth potential. qPCR Kits acceptance, medical professionals’ choice for genetic diseases treatments by qPCR tests, and rising healthcare costs are the primary factors boosting the global market growth. Due to the rising incidence of medical technology advancements, and investments in R&D activities, the pharmaceutical and healthcare industries have recently undergone significant changes. Growing public and private sector funding, pharmaceutical industry investments, medication discovery advancements, and market revenue growth contribute to this. During the COVID-19 pandemic, market growth expanded due to the increased demand for various qPCR kits. Furthermore, with increasing investment in the advancement of health care sectors, this market is expected to grow continuously in upcoming years.
Recent Market Developments:
In June 2022, Genetic PCR Solutions launched the qPCR Kit for the detection of the monkeypox virus.